CannaMD

NOVEMBER 6, 2019

Marijuana has long been used for pain in medical traditions around the world. Today, both patient experience and modern scientific research support claims of medical marijuana’s effectiveness for pain management. It is also known that marijuana targets the body’s pain receptors in ways similar to synthetic opioids.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

SpeedWeed

SEPTEMBER 17, 2021

Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. The millions of people afflicted with PTSD may soon have access to MDMA therapy, and we believe the millions suffering from TBI may experience similar relief in the future.”.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Veriheal

MAY 26, 2022

RoC also works to increase patients’ access to medical cannabis by helping U.S. Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play. To date, Veriheal’s global team has helped hundreds of thousands of patients gain access to medical cannabis.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

The Joint Blog

FEBRUARY 11, 2022

The data from this study is promising and reveals that CBD worked to inhibit the spread of a virus in human lung cell samples, which is huge news. However, it warrants further examination and exploration by science in the form of clinical trials, which is what many in the scientific community are calling for.

Clinical Trials 49

Clinical Trials CBD Conditions Data 49

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ?Orphan

DEA 66

DEA Clinical Trials THC Research and Development 66

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? During my tenure, I have found the medical marijuana educational gap to be one of the most significant educational gaps that impacts a very broad range of healthcare providers. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Canna Care Docs

DECEMBER 16, 2020

Make this year about you by taking the first step: finally getting your medical marijuana card. What is medical marijuana? Medical marijuana is the use of the marijuana plant or its chemicals to treat various diseases or conditions. What conditions is medical marijuana helpful for? Chronic pain. Multiple sclerosis.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Veriheal

APRIL 11, 2022

Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. This means that U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Healer

MARCH 26, 2021

THC is the main psychoactive compound in marijuana, while CBD is a non-intoxicating cannabinoid found in the cannabis plant. Gresh is under no illusions that his pain is cured, but he said using marijuana has improved his quality of life. The researchers stressed the need for large, well-designed clinical trials.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

MAY 29, 2022

Clinical Trials and Human Subject Protections. Before the drug approval process even begins, sponsors must initiate clinical investigations by first filing an Investigational New Drug Application (IND) with FDA. FDA’s approval of an IND will also require sufficient evidence that the trial will be safe for human subjects.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

The Joint Blog

NOVEMBER 4, 2019

.” However, as noted by NORML, around half of respondents “expressed discomfort in talking to their patients about medical cannabis options, a finding that is also consistent with prior data. Healthcare providers play a critical role in facilitating patient access to medical cannabis.

Therapy 42

Therapy Clinical Trials Conditions Patients 42

Veriheal

AUGUST 31, 2020

Data shows that Hispanic Americans are more interested in using cannabis and CBD for wellness than other groups and “is believed to be in part due to the connections between the Hispanic community and nature.” Differing brands of marijuana could interact with the already current use of general anesthesia,” Vaibhav theorizes. .

Research and Development 117

Research and Development Education Agriculture Patients 117

MMJ Recs

JUNE 15, 2022

Medical marijuana (MMJ) is used to treat pain from a wide variety of conditions or illnesses, including everything from chronic back pain to arthritis. Located in Midtown, this clinic provides patients with easy access to their doctors – you can text, live chat, or book online for same-day appointments.

Patients 52

Patients Treatment Clinical Trials Therapy 52

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

If you carefully analyze all of the states that have approved medical marijuana, you may notice a pattern among all the qualifying conditions these states list. The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Puff Puff Post

JANUARY 1, 2020

As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Nabiximol is a cannnabis derived drug that exited clinical trials in Spain. Various chemicals in marijuana effect the immune system in different ways. Effects of Cannabis Medications.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Cannabis Law Report

DECEMBER 7, 2021

However, despite the increased use of MCs in children, there is limited data regarding their safety and efficacy in this population for those different indications 11. A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents.

Safety 52

Safety Cannabinoids Events Data 52

Puff Puff Post

JANUARY 1, 2020

As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Nabiximol is a cannnabis derived drug that exited clinical trials in Spain. Various chemicals in marijuana effect the immune system in different ways. Effects of Cannabis Medications.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

The Cannigma

JUNE 15, 2021

THC is by far the most abundant and popular molecule in marijuana. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. Easy access.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Greencamp

AUGUST 16, 2018

Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Our body produces internal cannabinoids called endocannabinoids, and the compounds from the cannabis plant access the ECS in a similar manner as our own endocannabinoids. How to Get a Medical Marijuana Prescription in Canada.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. THC is considered “marijuana” or “cannabis.” increase in annual sales.

CBD 144

CBD Seed-To-Sale Food Access 144

Canna Law Blog

NOVEMBER 6, 2021

Despite overwhelming evidence that psilocybin is misclassified, this barrier restricts research, stifles competition and innovation, and inhibits access. But only if it is made affordable and accessible. Instead, qualifying evidence may come from adequate and well-controlled clinical trials. For two decades, U.S.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

CannaMD

MARCH 8, 2020

In January of 2020, the Journal of the American College of Cardiology published a review titled Marijuana Use in Patients With Cardiovascular Disease. As a result, the review would appear to be neither a cause for concern nor a complete dismissal of the potential risks associated with marijuana use as it relates to cardiovascular disease.

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

JANUARY 9, 2019

Now the former finance executive is on a mission to stamp out diabetes in some of the world’s worst-hit areas with a revolutionary marijuana treatment engineered by his firm, Phoenix Life Sciences International. Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Members of Congress voiced support for marijuana/AIDS research. Rick Doblin, Ph.D., and Michael Mithoefer, M.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

The Cannigma

APRIL 8, 2021

The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. You definitely deserve access to talk to someone like me. These cannabinoids that have come into our normal repertoire but haven’t been studied or consumed at the high-level, like for example, marijuana or high THC cannabis have.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. I know how to analyze data.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

The Joint Blog

FEBRUARY 18, 2020

Marijuana use is associated with a reduction in the use of attention-deficit hyperactivity disorder (ADHD) medications in patients diagnosed with the syndrome, according a new study published in the journal Rambam Maimonides and first reported on by NORML.

Clinical Trials 45

Clinical Trials Terpenes Data Cannabinoids 45

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

SMPL

MAY 26, 2020

A headstrong biochemist, she had been growing marijuana since the age of 14 and had just quit a six-figure job to start her own cannabis testing lab. In addition to convincing marijuana dispensaries to widely carry CBD, they wanted to educate the public about its promising benefits. San Francisco weekly.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

JULY 21, 2022

By decriminalizing cannabis at the federal level, the CAOA also ensures that state-legal cannabis businesses or those in adjacent industries will no longer be denied access to bank accounts or financial services simply because of their ties to cannabis. Marijuana Moment. Senate Democrats unveil long-awaited marijuana legalization bill.

Safety 52

Safety Legislation Clinical Trials Banking 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. In addition to serving on the Board of MAPS, he is also the Chairman of the Board of the Marijuana Policy Project. James Keim.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

SpeedWeed

DECEMBER 28, 2018

As first reported by Leafly, Altria has “over the past five years quietly patented dozens of devices that could be used to consume marijuana, a review of public documents at the US Patent and Trademark Office shows.” Which Cannabis Strains Are Highest in CBD, According to Lab Data? RELATED STORY. RELATED STORY.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

OCTOBER 17, 2019

Outsiders are coming in thinking that we’ll be passing legal recreational marijuana shortly and are willing to invest. Each has different levels of a compound called tetrahydrocannibinol (THC), which is what gives marijuana users their high. the THC levels that differentiate industrial hemp from marijuana).

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

SEPTEMBER 20, 2019

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. Dr. Sisley isn’t just trying to study medical marijuana; she’s trying to get cannabis flowers approved by the FDA as tried-and-true medicine. Dr. Sue Sisley.

DEA 231

DEA Research and Development Clinical Trials Patients 231